直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Ad Law Buzz Blog

No Presumption of Irreparable Harm in Lanham Act False Advertising Cases

October 23, 2014

Authored and Edited by Naresh Kilaru

The Court of Appeals for the Third Circuit recently considered whether plaintiffs bringing a Lanham Act false advertising claim and seeking a preliminary injunction are entitled to a presumption of irreparable harm upon showing a likelihood of success on the merits.  It joined the growing chorus of courts holding that no such presumption exists in view of the Supreme Court’s eBay decision.  Ferring Pharm., Inc. v. Watson Pharm., Inc., 765 F.3d 205 (3d Cir. 2014).

Plaintiff accused defendant of making certain false and misleading statements in two webcast presentations to doctors (the parties were competing manufacturers of pharmaceutical products).  The defendant conceded that certain of the statements were made in error and certified to the court that it would not repeat such statements in the future.  The defendant also agreed to clarify other statements moving forward.  The district court denied plaintiff’s motion for a preliminary injunction after finding that plaintiff failed to present sufficient evidence to demonstrate a likelihood of irreparable harm.

The plaintiff appealed the denial of its motion for a preliminary injunction, and the Third Circuit affirmed.  It noted that, prior to eBay, several circuit courts had applied a presumption of irreparable harm in Lanham Act false advertising cases.  Circuit courts after eBay, however, have “uniformly” held that a presumption of irreparable harm is no longer permissible.  As the Supreme Court noted in eBay, applying such a presumption deviates from traditional principles of equity requiring that a movant actually demonstrate the likelihood of irreparable harm.

In this case, the only evidence of irreparable harm submitted by the plaintiff was a declaration from a physician stating that she and other doctors would be less likely to prescribe the plaintiff’s drug after hearing the defendant’s allegedly false statements.  Like the district court, the Third Circuit found the declaration to be speculative because it did not state that the physician had, in fact, prescribed the plaintiff’s product less frequently.  The court also found no irreparable harm because the defendant had immediately removed certain of the statements from the webcast and agreed to clarify other statements moving forward.

This case is yet another post-eBay example of how the irreparable-harm factor is becoming the overriding factor in the preliminary injunction analysis.  Indeed, the district court in this case noted that it did not need to even consider the plaintiff’s likelihood of success on the merits given the failure to demonstrate a likelihood of irreparable harm.

Tags

eBay v. MercExchange, false advertising, preliminary injunction, irreparable harm

Related Practices

Trademark and Brand Management

Advertising

Contacts

Naresh Kilaru
Partner
Washington, DC
+1 202 408 4236
Email

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Ad Law Buzz Blog

How to Survive a Section 230 Defense: Recent Cases Provide Guidance

May 1, 2026

Articles

Recent Developments in Video Privacy Protection Act Litigation

April 3, 2026

Webinar

Generative AI Meets Copyright Law: US and UK Perspectives

April 1, 2026

Webinar

Webinar

Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents

March 12, 2026

Webinar

Federal Circuit IP Blog

Motion to Dismiss Vacated for Implicit Claim Construction Against Non-Movant

March 2, 2026

Webinar

Protect Your Innovations: Recent Patent Case Law in the Life Sciences

February 11, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP